Safety and efficacy of escalating doses of incobotulinumtoxinA (400-800U): Increasing improvements in disability due to multifocal upper- and lower-limb spasticity
Objective: To assess the safety and efficacy of escalating incobotulinumtoxinA doses (400-800U) in patients with spasticity. Background: Botulinum toxin treatment at higher doses than currently…An innovative international educational network to improve physicians’ current management practices of patients with cervical dystonia and spasticity
Objective: The Ixcellence Network® aims to improve patient care in the fields of cervical dystonia (CD) and spasticity through the development of a high level…Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease
Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
- « Previous Page
- 1
- …
- 4
- 5
- 6